openPR Logo
Press release

Transgenic Animal Model Market Forecast 2025-2035: Growth, Trends, and Future Outlook

02-24-2026 10:24 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

The global transgenic animal model market is projected to reach $6,799.3 million by 2035, growing at a CAGR of 9.29% during the forecast period 2025-2035. The market is expanding steadily due to rising demand for precision medicine, rapid advancements in

The global transgenic animal model market is projected to reach $6,799.3 million by 2035, growing at a CAGR of 9.29% during the forecast period 2025-2035. The market is expanding steadily due to rising demand for precision medicine, rapid advancements in

Transgenic animal models play a critical role in oncology, immunology, rare disease research, and biologics development by enabling highly accurate preclinical testing. Growth in cell and gene therapies, expanding pharmaceutical R&D pipelines, and increased public-private research collaborations are further accelerating adoption.
According to BIS Research, the global [https://bisresearch.com/industry-report/transgenic-animal-model-market.html?utm_source=Monika&utm_medium=Abnewswire&utm_campaign=monika_pr]is projected to reach $6,799.3 million by 2035, growing at a compound annual growth rate (CAGR) of 9.29% during the forecast period 2025-2035. The market is witnessing strong momentum driven by the increasing adoption of genetically engineered animal models in drug discovery, oncology research, immunology studies, and rare disease modeling.

Transgenic animal models organisms whose genomes have been deliberately modified using genetic engineering techniques have become foundational tools in modern biomedical research. With the rise of gene-editing platforms such as CRISPR/Cas9, TALENs, and zinc-finger nucleases, researchers can now create highly precise disease models that closely mimic human pathophysiology, significantly improving preclinical study accuracy and translational outcomes.

What Are Transgenic Animal Models and Why Are They Important in Biomedical Research?

Transgenic animal models are genetically engineered organisms whose genomes have been modified to replicate specific human disease characteristics. These models are essential tools in:

*
Drug discovery and development

*
Oncology research

*
Immunology studies

*
Rare genetic disease modeling

*
Neuroscience and cardiovascular research

With the rise of gene-editing platforms such as CRISPR/Cas9, TALENs, and zinc-finger nucleases, researchers can now create highly precise disease models that significantly improve translational accuracy and preclinical validation outcomes.

Market Overview

The projected market value of $6.8 billion by 2035 reflects sustained investment in life sciences research, growing clinical trial pipelines, and rising focus on personalized medicine.

Key Growth Indicators:

*
Market Size by 2035: $6,799.3 million

*
Forecast Period: 2025-2035

*
CAGR (2025-2035): 9.29%

Request A Sample [https://bisresearch.com/requestsample?id=3492&type=download&utm_source=Monika&utm_medium=Abnewswire&utm_campaign=monika_pr] for Transgenic Animal Model Market - Focus on Application, Product, and Regional Analysis and Forecast, 2025-2035

What Is Driving Growth in the Transgenic Animal Model Market?

Several structural factors are accelerating market growth:

1. How Is Precision Medicine Increasing Demand for Transgenic Models?

Precision medicine requires disease models that replicate specific genetic mutations and biological pathways. Transgenic models enable targeted therapy testing and biomarker validation, particularly in oncology and rare diseases.

2. How Are CRISPR and Gene-Editing Technologies Transforming Model Development?

CRISPR/Cas9 has revolutionized genetic engineering by offering faster, more cost-effective, and highly accurate genome modification. This technology has significantly reduced model development timelines and expanded access to advanced research institutions and biotech companies.

3. How Is the Growth of Biologics and Cell & Gene Therapies Impacting the Market?

The expansion of biologics, CAR-T therapies, monoclonal antibodies, and gene therapies has increased the need for advanced preclinical models. Transgenic animals are critical for assessing therapeutic efficacy, toxicity, immunogenicity, and long-term safety before clinical trials.

4. How Does Increased Research Funding Support Market Expansion?

Rising global R&D investments and public-private collaborations are expanding research capabilities. Pharmaceutical companies, academic institutions, and contract research organizations (CROs) are increasing partnerships to develop specialized transgenic models.

Market Segmentation Insights

The transgenic animal model market can be segmented based on animal type, technology, application, and end user.

Which Animal Types Dominate the Transgenic Animal Model Market?

Rodents, particularly mice and rats, dominate the market due to:

*
High genetic similarity to humans

*
Short reproductive cycles

*
Established genomic data

Large animal models such as pigs and non-human primates are gaining traction in specialized applications, including cardiovascular research, xenotransplantation, and neurological disorder studies.

Which Gene-Editing Technologies Are Leading Market Adoption?

Key technologies include:

*
CRISPR/Cas9

*
TALEN

*
Zinc-Finger Nucleases

*
Microinjection

*
Embryonic Stem Cell-Mediated Gene Transfer

CRISPR-based approaches are expected to lead due to their precision, scalability, and lower cost compared to traditional gene-targeting techniques.

What Are the Primary Applications of Transgenic Animal Models?

Major application areas include:

*
Oncology research

*
Immunology

*
Neurodegenerative disorders

*
Cardiovascular diseases

*
Rare genetic diseases

*
Metabolic disorders

*
Drug discovery and development

Oncology represents a significant revenue segment, driven by the need to replicate complex tumor microenvironments and immuno-oncology pathways.

Who Are the Key End Users in the Transgenic Animal Model Market?

The primary end users include:

*
Pharmaceutical & biotechnology companies

*
Academic & research institutes

*
Contract research organizations (CROs)

Pharmaceutical and biotech firms account for a major market share due to expanding R&D pipelines and increasing reliance on predictive preclinical platforms.

Why Does North America Dominate the Global Market?

North America holds a dominant position due to:

*
Advanced research infrastructure

*
High R&D expenditure

*
Strong pharmaceutical and biotechnology presence

*
Robust regulatory frameworks

How Is Asia-Pacific Emerging as a High-Growth Region?

The Asia-Pacific region is projected to experience significant growth during 2025-2035, supported by expanding biotech industries in China, Japan, South Korea, and India, along with increased outsourcing and government funding initiatives.

Click Here to Download the ToC [https://bisresearch.com/requestsample?id=3492&type=toc&utm_source=Monika&utm_medium=Abnewswire&utm_campaign=monika_pr]

What Emerging Trends Are Shaping the Future of Transgenic Animal Models?

1. Why Are Humanized Animal Models Gaining Importance?

Humanized mouse models, engineered with human genes or immune systems, are becoming essential in immuno-oncology and infectious disease research.

2. How Are Ethical Regulations Influencing Model Development?

Regulatory emphasis on the 3Rs principle (Replacement, Reduction, and Refinement) is driving innovation in model efficiency, minimizing animal use while maximizing data output.

3. How Is AI Integration Enhancing Preclinical Research?

The integration of artificial intelligence and digital biology with transgenic research is improving predictive modeling, data interpretation, and study optimization.

Get More Insight for Healthcare Market [https://bisresearch.com/industry-verticals/healthcare-medical?utm_source=Monika&utm_medium=Abnewswire&utm_campaign=monika_pr]

The global transgenic animal model market is projected to grow to $6,799.3 million by 2035 at a CAGR of 9.29%, reflecting the increasing importance of advanced preclinical research tools.

As therapeutic pipelines become more complex and personalized medicine advances, transgenic models will remain essential for accelerating innovation, improving translational success rates, and reducing clinical trial failure risks.

About BIS Research

BIS Research, recognized as a top market research company, specializes in market research reports and advisory services focused on deep technology and emerging trends that are poised to disrupt key industrial markets. Annually, we publish over 1000+ market intelligence reports across various deep technology verticals. We help businesses stay ahead with in-depth reports, custom research [https://bisresearch.com/our-offerings/custom-research?utm_source=abnewswireMonika&utm_medium=Abnewswire&utm_campaign=Monika_pr], and go-to-market strategies tailored to your goals.

Media Contact
Company Name: BIS Research
Contact Person: Bhavya Banga
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=transgenic-animal-model-market-forecast-20252035-growth-trends-and-future-outlook]
Phone: +1-510-404-8135
Address:39111 PASEO PADRE PKWY STE 313, FREMONT CA 94538
Country: United States
Website: https://bisresearch.com/industry-report/transgenic-animal-model-market.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transgenic Animal Model Market Forecast 2025-2035: Growth, Trends, and Future Outlook here

News-ID: 4403736 • Views:

More Releases from ABNewswire

Cheapest ZZ Top Tickets 2026: Dos Amigos Tour Dates - Promo CITY10 CapitalCityTickets.com - All Seating Available
Cheapest ZZ Top Tickets 2026: Dos Amigos Tour Dates - Promo CITY10 CapitalCityTi …
ZZ Top teams up with Dwight Yoakam for the epic Dos Amigos Tour in 2026! Spring run starts March 26 at Dacotah Bank Center (Brookings, SD), hits INTRUST Bank Arena (Wichita, KS, Mar 28), Simmons Bank Arena (North Little Rock, AR, Apr 17), Orion Amphitheater (Huntsville, AL, Apr 18), Azura Amphitheater (Bonner Springs, KS, Apr 25), Lauridsen Amphitheater (Des Moines, IA, May 7), Koka Booth Amphitheatre (Cary, NC, May 22),
Daniel Tosh 2026 Comedy Tour Tickets | Cheapest Seats for My First Farewell + CITY10 Promo Code at CapitalCityTickets.com
Daniel Tosh 2026 Comedy Tour Tickets | Cheapest Seats for My First Farewell + CI …
Daniel Tosh launches his savage My First Farewell Tour in 2026! North American run features sharp stand-up at Arlene Schnitzer (Portland, Jan 8), Paramount Theatre (Seattle, Jan 9), Yaamava' Theater (Highland, CA, Mar 12), Wheeler Opera House (Aspen, CO, Mar 14-15), Stephens Auditorium (Ames, IA, Mar 25), multiple dates at The Chelsea at The Cosmopolitan (Las Vegas, e.g., Feb 7, Apr 25, Sept 26, Nov 7), and more through fall. Comedy
Gordon Law, P.C. - Queens Family and Divorce Lawyer Explains How 2026 NY Child Support Modification Law Changes Affect Incarcerated Parents and Family Court Petitions
Gordon Law, P.C. - Queens Family and Divorce Lawyer Explains How 2026 NY Child S …
Gordon Law, P.C. - Queens Family and Divorce Lawyer has established itself among the best family law attorneys in Queens by consistently delivering personalized legal solutions with a balance of expertise and empathy. Their experienced team understands that family disputes are deeply personal, which is why they prioritize clear communication, thorough preparation, and results-driven representation in every case they handle. QUEENS, NY - February 24, 2026 - Gordon Law, P.C. -
Augure Enters the AI Race Against OpenAI and Anthropic - Staking Its Claim on Canadian Data Sovereignty for Regulated Markets
Augure Enters the AI Race Against OpenAI and Anthropic - Staking Its Claim on Ca …
Canadian startup Augure launches a sovereign AI platform that directly challenges OpenAI and Anthropic for regulated professionals. By hosting all data on Montreal servers, Augure eliminates US CLOUD Act exposure for defense contractors, lawyers, and therapists. The platform arrives as CPCSC deadlines, Law 25, and PIPEDA compliance pressures make US-hosted AI tools untenable for Canadian organizations. TORONTO, ON - In an AI market dominated by American hyperscalers, a Canadian company is

All 5 Releases


More Releases for Transgenic

Rising Agricultural Productivity Fuels Growth In The Transgenic Seed Market: Tra …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Transgenic Seeds Industry Market Size Be by 2025? The market size for transgenic seeds has witnessed swift expansion in the past few years. The growth is projected to increase from $49.86 billion in 2024 to $56.87 billion in 2025, exhibiting a compound annual growth rate (CAGR)
Rising Agricultural Productivity Fuels Growth In The Transgenic Seed Market Driv …
What industry-specific factors are fueling the growth of the transgenic seeds market? The upsurge in agricultural productivity is projected to stimulate the expansion of the transgenic seed market. This productivity signifies the crop yield's market value produced by an agricultural system that employs inputs like land, labor, capital, and other resources. The primary use of transgenic seeds is in agriculture to cultivate more food using fewer resources. The application of transgenic
Transgenic Seeds Market Size, Share, Growth, Forecast 2024 To 2033
The Business Research Company offers in-depth market insights through Transgenic Seeds Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The transgenic seeds market size has grown rapidly in recent years. It will grow from $44.02 billion in 2023 to $50.24 billion in 2024 at a compound annual growth rate (CAGR) of
Transgenic Seeds Market Size, Share, Growth, Forecast 2024 To 2033
The Business Research Company offers in-depth market insights through Transgenic Seeds Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The transgenic seeds market size has grown rapidly in recent years. It will grow from $44.02 billion in 2023 to $50.24 billion in 2024 at a compound annual growth rate (CAGR) of
Transgenic Seeds Market Analysis, Trends, Growth, Research And Forecast 2032
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Transgenic Seeds Market Size, Growth Rate, And Forecast The global transgenic seeds market size is expected to grow from $38.54 billion in 2022 to $44.02 billion in 2023 at a compound annual growth rate (CAGR) of 14.2%. The Russia-Ukraine war disrupted the chances of global economic recovery
Global Mice Model Market |mice model, transgenic mice, knockout mice, knockout m …
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Mice Model Market “ Mouse is a popular model system because it is a mammal with sophisticated genetic tools and significant genetic resources. The prospect of the mice as a model for exploring human pathophysiology and disease progression and for developing drugs is